|
Medtronic received a report that distal end of the pipeline could not be opened.Repeated attempts were tried but the issue persisted, so the device was removed from the patient's body.Upon removal it was found that the tip of the pipeline was burr-like.The device was replaced and the procedure completed successfully.The patient was undergoing treatment of an unruptured, saccular right cavernous sinus aneurysm with a diameter of 15x13mm and a neck width of 4mm.Dual antiplatelet treatment was administered.It was noted that the patient's vessel tortuosity was normal.The devices were prepared as indicated per the ifu.The device was not placed in a bend and less than 50% of the device was deployed when it failed to open.More than 2 resheathing attempts were made and no addition a steps were taken to open the device.Ancillary devices include a 6f navien guide catheter.
|
|
H3: analysis of the pipeline embolization device (lot no.B118643) found that the distal and proximal dps restraints were intact.The dps sleeves were found intact with no signs of damage.The distal hypotube and ptfe shrink tubing were found to be intact with no signs of elongation.The distal and proximal ends of the pipeline flex braid were fully opened and moderately frayed.No bend found on the pusher.No damages were found with the tip coil, distal marker, re-sheathing marker or with the proximal bumper.No other anomalies were observed.Based on the returned device, the pipeline flex was not confirmed to have failure to open at the distal end as the distal and proximal ends of pipeline flex braid were fully opened and moderately frayed.The damage to the braid on the ends of the pipeline flex braid is likely the results of the physician re-sheathing the device more than recommended two times.Possible cause includes patient tortuous anatomy.There was no non-conformance to specifications identified that led to the failure to open issue.H6: method code updated to b01.Result code updated to c070601.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|